^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Steroid receptor agonist

3d
Nail Langerhans Cell Histiocytosis: A Rare Case Series of Two Patients With Single-System and Multisystem Disease Presenting With Nail Lesions. (PubMed, Am J Dermatopathol)
Systemic chemotherapy with vinblastine and prednisone led to marked improvement in nail, skin, pulmonary, and osseous lesions. These cases illustrate that nail changes may be the earliest manifestation of LCH and should prompt thorough systemic evaluation. Early recognition of nail involvement can facilitate timely diagnosis and risk-adapted treatment, potentially improving outcomes in affected patients.
Journal
|
BRAF (B-raf proto-oncogene)
|
BRAF V600E • BRAF V600
|
prednisone • vinblastine
7d
eo-Drive: Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation (clinicaltrials.gov)
P3, N=182, Terminated, University Hospital, Montpellier | N=600 --> 182 | Recruiting --> Terminated; low enrollment at participating centers
Enrollment change • Trial termination
|
prednisone
7d
Trial completion
|
dexamethasone injection
8d
Enrollment open
|
dexamethasone injection
8d
New trial
|
dexamethasone injection
11d
Trial completion
|
dexamethasone injection
13d
Post-op Prednisone and Glucose Monitoring in TKA (clinicaltrials.gov)
P4, N=104, Not yet recruiting, Columbia University
New P4 trial
|
prednisone
15d
Case report: superficial kaposiform hemangioendothelioma without the Kasabach-Merritt phenomenon. (PubMed, Front Oncol)
Upon confirming KHE diagnosis, we initiated a combined sirolimus and prednisone treatment. In this report, we also discuss the clinical manifestations, imaging features, histopathological characteristics, and treatment options for this KHE subtype and review relevant literature. This case highlights the diagnostic features and therapeutic considerations of superficial KHE without KMP, emphasizing the importance of multidisciplinary evaluation.
Journal
|
CD34 (CD34 molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) • SLC2A1 (Solute Carrier Family 2 Member 1)
|
prednisone • sirolimus
17d
Protective Effects of Adipose-derived Stem Cell Exosomes vs Dexamethasone on Neuromotor Deficits in Focal Cerebral Ischemia. (PubMed, Basic Clin Neurosci)
Exosomes were administered intravenously, while dexamethasone was given intraperitoneally...Their multi-modal mechanisms-including anti-inflammatory, anti-apoptotic, angiogenic, and neuroregenerative effects-highlight their potential as a novel therapeutic approach for stroke management. Future research should focus on clinical translation, dosage optimization, and long-term safety evaluation.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha)
|
dexamethasone injection
20d
Dexamethasone for Ureteral STent Symptoms (DUSTS) (clinicaltrials.gov)
P1/2, N=70, Recruiting, The Methodist Hospital Research Institute | Not yet recruiting --> Recruiting
Enrollment open
|
dexamethasone injection
20d
Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery (clinicaltrials.gov)
P4, N=176, Enrolling by invitation, University Medical Center Ho Chi Minh City (UMC)
New P4 trial • Adverse events
|
dexamethasone injection